JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB171941

Anti-FGF21 antibody [EPR8314(2)]

  • RabMAb
  • Recombinant
  • KO Validated
  • 20ul selling size
  • What is this?

3

(1 Review)

|

(119 Publications)

Anti-FGF21 antibody [EPR8314(2)] (ab171941) is a rabbit monoclonal antibody detecting FGF21 in Western Blot, IHC-P. Suitable for Human, Mouse, Rat.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 80 publications

View Alternative Names

UNQ3115/PRO10196, FGF21, Fibroblast growth factor 21, FGF-21

3 Images
Western blot - Anti-FGF21 antibody [EPR8314(2)] (AB171941)
  • WB

Unknown

Western blot - Anti-FGF21 antibody [EPR8314(2)] (AB171941)

Blocking buffer : 5% NFDM/TBST

Dilution buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-FGF21 antibody [EPR8314(2)] (ab171941) at 1/5000 dilution

All lanes:

Human fetal liver tissue lysate at 20 µg

Secondary

All lanes:

HRP goat anti-rabbit (H+L) at 1/1000 dilution

Predicted band size: 22 kDa

Observed band size: 22 kDa

false

Western blot - Anti-FGF21 antibody [EPR8314(2)] (AB171941)
  • WB

Lab

Western blot - Anti-FGF21 antibody [EPR8314(2)] (AB171941)

False colour image of Western blot : Anti-FGF21 antibody [EPR8314(2)] staining at 1/1000 dilution, shown in black; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab171941 was shown to bind specifically to FGF21. A band was observed at 21 kDa in treated wild-type HeLa cell lysates with no signal observed at this size in FGF21 knockout cell line ab265974 (knockout cell lysate ab256915). To generate this image, wild-type and FGF21 knockout HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times before development and with high-sensitivity chemiluminescence substrate and imaged with 16 minutes exposure time. Secondary antibodies used were HRP conjugated Goat anti-Rabbit (H+L) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed at 1/20000 dilution.

All lanes:

Western blot - Anti-FGF21 antibody [EPR8314(2)] (ab171941) at 1/1000 dilution

Lane 1:

Wild-type HeLa Treated BFA (5 ug/mL, 6 h) cell lysate at 20 µg

Lane 2:

FGF21 knockout HeLa Treated BFA (5 ug/mL, 6 h) cell lysate at 20 µg

Lane 3:

Wild-type HeLa Vehicle Control BFA (0 ug/mL, 6 h) cell lysate at 20 µg

Lane 4:

FGF21 knockout HeLa Vehicle Control BFA (0 ug/mL, 6 h) cell lysate at 20 µg

Lane 5:

HepG2 Treated BFA (5 ug/mL, 6 h) cell lysate at 20 µg

Lane 6:

HepG2 cell lysate at 20 µg

Lane 7:

Empty

Lane 8:

Human Liver cell lysate at 10 µg

Secondary

All lanes:

HRP conjugated Goat anti-Rabbit (H+L) and Goat anti-Mouse IgG H&L (IRDye® 680RD) at 1/20000 dilution

Predicted band size: 22 kDa

Observed band size: 21 kDa

false

Western blot - Anti-FGF21 antibody [EPR8314(2)] (AB171941)
  • WB

Unknown

Western blot - Anti-FGF21 antibody [EPR8314(2)] (AB171941)

Blocking buffer : 5% NFDM/TBST

Dilution buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-FGF21 antibody [EPR8314(2)] (ab171941) at 1/5000 dilution

All lanes:

Rat spleen tissue lysate at 20 µg

Secondary

All lanes:

HRP goat anti-rabbit (H+L) at 1/1000 dilution

Predicted band size: 22 kDa

Observed band size: 22 kDa

false

  • Carrier free

    Anti-FGF21 antibody [EPR8314(2)] - BSA and Azide free

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-FGF21 antibody [EPR8314(2)]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-FGF21 antibody [EPR8314(2)]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-FGF21 antibody [EPR8314(2)]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-FGF21 antibody [EPR8314(2)]

  • 578 PE

    PE Anti-FGF21 antibody [EPR8314(2)]

  • 660 APC

    APC Anti-FGF21 antibody [EPR8314(2)]

  • 775 Alexa Fluor® 750

    Alexa Fluor® 750 Anti-FGF21 antibody [EPR8314(2)]

  • Carrier free

    Anti-FGF21 antibody [EPR8314(2)] - Low endotoxin, Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR8314(2)

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

IHC-P, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

The immunogen used for this product shares 6 continuous identical amino acids with SIKE1. Cross-reactivity with this protein has not been confirmed experimentally.

Expression levels of the target protein vary with sample type and some optimisation may be required (PMID: 27285327). For western blot using cell lines, it may be necessary to collect cell culture supernatant for endogenous FGF21 detection as the target protein is readily secreted (PMID: 24041694; PMID: 26691139).

ab171941 is not recommended for mouse WB or human IHC-P.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "1/250", "IHCP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "1/250", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "1/250", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

What is this antibody validated in?
Anti-FGF21 antibody [EPR8314(2)] (ab171941) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P) in Human, Mouse, Rat samples.

What is the molecular weight of FGF21?
Anti-FGF21 [EPR8314(2)] (ab171941) specifically detects a band for FGF21 (UniProt: Q9NSA1) at a molecular weight of 22kDa.

Trusted by the scientific community
Anti-FGF21 [EPR8314(2)] (ab171941) was first used in a scientific publication in 2013 and has been cited over 80 times in peer-reviewed journals.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-FGF21 antibody [EPR8314(2)] (ab171941) has been confirmed by Western blot testing in FGF21 Knockout HeLa cell line, ab265974.

Other related products
We have a range of other formats of antibody clone [EPR8314(2)] also available for your convenience: ab171941, Carrier free - ab219368, Carrier free - ab271925, Alexa Fluor® 488 - ab322214, Alexa Fluor® 647 - ab322215, Alexa Fluor® 555 - ab322216, Alexa Fluor® 594 - ab322217, PE - ab322218, APC - ab322219, Alexa Fluor® 750 - ab322220

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Allow to warm to room temp and agitate gently before aliquoting
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

FGF21 or fibroblast growth factor 21 is an important metabolic regulator. It is a member of the fibroblast growth factor family but unlike many others FGF21 functions mainly in endocrine signaling. The molecular weight of FGF21 is approximately 22 kDa. This protein is expressed in tissues such as the liver adipose tissue and pancreas. Because of its endocrine roles FGF21 travels through the bloodstream to exert its functions on distant organs.
Biological function summary

FGF21 influences glucose and lipid metabolism. It does not act as part of a larger protein complex. Instead it directly affects metabolic processes enhancing insulin sensitivity and lipid oxidation while reducing body weight. These actions help maintain energy balance and homeostasis making FGF21 an important player in metabolic control.

Pathways

FGF21 plays a significant role in the insulin signaling pathway and PPARγ coactivator 1α (PGC-1α) pathway. These pathways regulate cellular energy metabolism and mitochondrial biogenesis respectively. FGF21 interacts with other molecules such as PPARα (peroxisome proliferator-activated receptor alpha) to exert its effects demonstrating its integration into broader metabolic networks. FGF21's interaction with these pathways highlights its function in energy utilization and storage.

FGF21 has connections to conditions such as obesity and type 2 diabetes. Its role in improving insulin sensitivity and promoting lipid oxidation makes it a molecule of interest in combating metabolic syndrome. FGF21 also has a relationship with hepatic proteins such as insulin receptor substrates (IRS) which play roles in liver functioning. Understanding these relationships offers insights into potential therapeutic strategies targeting metabolic disorders.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Stimulates glucose uptake in differentiated adipocytes via the induction of glucose transporter SLC2A1/GLUT1 expression (but not SLC2A4/GLUT4 expression). Activity requires the presence of KLB. Regulates systemic glucose homeostasis and insulin sensitivity.
See full target information FGF21

Publications (119)

Recent publications for all applications. Explore the full list and refine your search

Journal of neuroinflammation 22:170 PubMed40581646

2025

Genetically-engineered Salmonella typhimurium expressing FGF21 promotes neurological recovery in ischemic stroke via FGFR1/AMPK/mTOR pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Dongchen Xu,Min Wen,Bingwa Lebohang Anesu,Xijun Chen,Yuhao Chen,Wenqi Qian,Chenguang Yang,Jin Hai Zheng,Yinan Zhou,Haoqi Ni,Kunlin Jin,Qichuan Zhuge,Su Yang

Animal nutrition (Zhongguo xu mu shou yi xue hui) 21:207-221 PubMed40487094

2025

Fibroblast growth factor 21/extracellular signal-regulated kinase 1/2 pathway as a key link mediates the effects of low-protein diet on skeletal muscle fiber type transformation in pigs.

Applications

Unspecified application

Species

Unspecified reactive species

Shuo Li,Pengbo Liang,Bo Wang,Jun Chen,Jinming You,Tiande Zou

Nature communications 16:5001 PubMed40442121

2025

hpCasMINI: An engineered hypercompact CRISPR-Cas12f system with boosted gene editing activity.

Applications

Unspecified application

Species

Unspecified reactive species

Shufeng Ma,Kaitong Liao,Kechen Chen,Tong Cheng,Xiaofeng Yang,Peihan Chen,Sijie Li,Mengrao Li,Xin Zhang,Yanqun Zhang,Tao Huang,Xiaobo Wang,Lanfeng Wang,Ying Lin,Zhili Rong

Scientific reports 15:13096 PubMed40240774

2025

Glucosamine induces hepatic FGF21 expression by activating the Akt/mTOR/p70S6K axis and driving PGC-1α activity.

Applications

Unspecified application

Species

Unspecified reactive species

Shui-Yu Liu,Luen-Kui Chen,Pin-Hsuan Li,Guan-Lin Wu,Tsung-Hui Wu,Yuan-Bin Yu,Heng-Fu Lin,Chi-Chang Juan

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 12:e2415556 PubMed40162496

2025

In Vivo Reprogramming of Tissue-Derived Extracellular Vesicles for Treating Chronic Tissue Injury Through Metabolic Engineering.

Applications

Unspecified application

Species

Unspecified reactive species

Meng Zhao,Shuyun Liu,Yizhuo Wang,Peng Lou,Ke Lv,Tian Wu,Lan Li,Qianyi Wu,Jiaying Zhu,Yanrong Lu,Meihua Wan,Jingping Liu

Science advances 11:eadt3142 PubMed40138418

2025

The clinical antiprotozoal drug halofuginone promotes weight loss by elevating GDF15 and FGF21.

Applications

Unspecified application

Species

Unspecified reactive species

Suowen Xu,Zhenghong Liu,Tian Tian,Wenqi Zhao,Zhihua Wang,Monan Liu,Mengyun Xu,Fanshun Zhang,Zhidan Zhang,Meijie Chen,Yanjun Yin,Meiming Su,Wenxiang Fang,Wenhao Pan,Shiyong Liu,Min-Dian Li,Peter J Little,Danielle Kamato,Songyang Zhang,Dongdong Wang,Stefan Offermanns,John R Speakman,Jianping Weng

Acta pharmacologica Sinica 46:1834-1851 PubMed40021824

2025

FGF21, a modulator of astrocyte reactivity, protects against ischemic brain injury through anti-inflammatory and neurotrophic pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Dong-Xue Wang,Wen-Ting Huang,Jun-Feng Shi,Fei Liu,Wen-Yi Jiang,Ke-Yang Chen,Shu-Yang Zhang,Xiao-Kun Li,Li Lin

Veterinary sciences 12: PubMed40005931

2025

Establishment of a Direct Competitive ELISA for Camel FGF21 Detection.

Applications

Unspecified application

Species

Unspecified reactive species

Yuxuan Yang,Hong Yuan,Yunjuan Jiao,Shuqin Zhao,Yuanfang Fu,Xingwen Bai,Zengjun Lu,Yuan Gao

Nature communications 16:1661 PubMed39955281

2025

FGF21 protects against HFpEF by improving cardiac mitochondrial bioenergetics in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Ke Zhang,Jing Gan,Baile Wang,Wei Lei,Dong Zhen,Jie Yang,Ningrui Wang,Congcong Wen,Xiaotang Gao,Xiaokun Li,Aimin Xu,Xinguang Liu,Yulin Li,Fan Wu,Zhuofeng Lin

Journal of translational medicine 23:122 PubMed39871339

2025

FGF21 and APOA1 mRNA-based therapies for the treatment of experimental acute pancreatitis.

Applications

Unspecified application

Species

Unspecified reactive species

Amaya Lopez-Pascual,Eva Santamaria,Nuria Ardaiz,Iker Uriarte,Tiffany Palmer,Anne-Renee Graham,Celia Gomar,Roberto C Barbero,M Ujue Latasa,Maria Arechederra,Jesus M Urman,Carmen Berasain,Antonio Fontanellas,Carlos L Del Rio,Maite G Fernandez-Barrena,Paolo G V Martini,Joshua R Schultz,Pedro Berraondo,Matias A Avila
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com